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Historically, measurement of clinical outcomes was not a
feature of routine clinical practice. Physiotherapists (and, for
that matter, most other health professionals) did not
systematically collect data on patients’ outcomes. Typically
physiotherapists obtained incidental impressions of clinical
outcomes from clinical observations, or from patients’
comments about satisfaction (or dissatisfaction) with
physiotherapy services.
In more recent times there has been pressure on
physiotherapists to become more accountable for their
practices. The pressure has come from makers of health care
policies, those who allocate and fund health care
(government, insurers, managers), and from within the
physiotherapy profession. One of the driving forces has been
the perception that physiotherapists must justify what they do.
It is thought that by providing evidence of good clinical
outcomes physiotherapists can demonstrate that what they do
is worthwhile.
In the last two decades the physiotherapy profession has
taken up the call for more and better clinical measurement.
An early landmark was the publication, in 1985, of
Measurement in Physical Therapy (Rothstein 1985). More
recently there has been a proliferation of textbooks, journal
features, and web sites documenting clinical outcome
measures and their measurement properties (see, for example,
Wade 1992, Koke et al 1999, Maher et al 2000 and Finch et
al 2002). In some countries at least, a large proportion of
physiotherapists routinely document clinical outcomes using
validated tools. In New South Wales, WorkCover pays an
additional fee to practitioners who adequately document
measures of clinical outcomes.
Perhaps it is unfortunate that the physiotherapy profession
has responded to the perception that physiotherapists must
justify what they do by routinely measuring clinical
outcomes. The implication is that measures of outcome can
provide justification for intervention. Arguably that is not the
case. Outcome measures measure outcomes. They do not
measure the effects of intervention. Outcomes of
interventions and effects of interventions are very different
things.
Clinical outcomes are influenced by many factors other than
intervention, including the natural course of the condition,
statistical regression, placebo effects, and so on. (Tuttle
(2005) makes this point clearly in his article, in this issue, on
the predictive value of clinical outcome measures.) The
implication is that a good outcome does not necessarily
indicate that intervention was effective; the good outcome
may have occurred even without intervention. And a poor
outcome does not necessarily indicate that intervention was
ineffective; the outcome may have been worse still without
intervention. This is why proponents of evidence-based
physiotherapy, including ourselves (Herbert et al 2005), argue
it is necessary to look to randomised trials to determine, with
any degree of certainty, the effects of intervention. It is
illogical, on the one hand, to look to randomised controlled
trials for evidence of effects of interventions while, on the
other hand, seeking justification for the effectiveness of
clinical practice with uncontrolled measurement of clinical
outcomes.
Taken further, this line of reasoning suggests that, at least in
some circumstances, measures of individual patients’ clinical
outcomes should have no role in influencing decisions about
treatment for those patients. According to this extreme view,
randomised trials provide better information about the effects
of intervention than do measures of clinical outcomes. So
decisions about intervention for a particular patient should be
based entirely on the findings of randomised trials, without
regard to the apparent effects of treatment suggested by
measures of clinical outcome on that patient. For example, if
a randomised trial suggests that, on average, an intervention
produces effects that a patient considers would be
worthwhile, the implication is that intervention should
continue to be offered even if the patient’s outcomes are poor.
The reasoning goes that the best we can know of the effects
of a treatment (from randomised trials) tells us that this
intervention typically produces clinically worthwhile effects.
The patient may be one of the unlucky patients who does not
benefit from (or is harmed by) this intervention, or it may be
that the patient’s poor outcomes might have been worse still
without the intervention. We cannot discriminate between
these scenarios so we act on the basis of what we think is
most likely to be true: on average the intervention is helpful.
Consequently we continue to provide the intervention even
though the outcome of intervention is poor.
This view is completely antithetical to the empirical approach
to clinical practice exemplified by some authors, and notably
by Maitland in his classic texts on manual therapy (Maitland
et al 2001). In the fully empirical approach, intervention is
always followed by assessment of clinical outcomes. If
outcomes improve, the intervention may be continued until
the problem is completely resolved. If outcomes do not
improve or worsen, the intervention is modified or
discontinued. This approach appears to be reasonable, but it
involves making clinical decisions on the basis of information
that is very difficult to interpret. The empirical approach, in
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which clinical decisions are based on careful measurement of
outcomes, is not evidence-based physiotherapy. If we base
clinical decisions about intervention on high quality clinical
research, measures of clinical outcome need have little role in
clinical decision-making or in justifying clinical practice.
Interventions can be recommended without consideration of
their outcomes.
Is there any role for clinical outcome measures in clinical
decision making? We think that, when there is evidence of
effects of intervention from high quality clinical trials, a
sensible approach to clinical decision-making lies somewhere
between the two extremes of the fully empirical approach and
a hard-line approach in which clinical decision-making is
based only on high quality clinical research without regard to
outcome. In this approach, extreme clinical observations
(very good or very poor outcomes) are considered likely to be
‘real’ (bias is unlikely to have qualitatively altered the clinical
picture), so they are used to guide clinical decision-making.
On the other hand, the qualitative interpretation of typical
observations (small improvements in outcome) could
plausibly be altered by bias, so they are essentially ignored. In
other words, this approach suggests that clinical decision
making should be influenced by observations of very good
and very poor outcomes, but should not be influenced by less
extreme observations.
What does this mean in practice? It means, first of all, that
there is value in careful measurement of clinical outcomes,
because extreme clinical outcomes influence clinical decision
making. It also means that the degree of regard we pay to
measures of clinical outcome depends on how extreme the
outcomes are. When outcomes are very poor we should
discontinue the intervention, even if the best clinical trials tell
us that the intervention is, on average, effective, because a
very poor outcome is unlikely to be explicable just by
confounding effects such as the natural course of the
condition, statistical regression, and so on — it probably also
reflects that this person truly responded poorly to the
intervention. On the other hand, less extreme poor outcomes
might reasonably be ignored, and an intervention might be
persisted with regardless of moderately poor outcome if the
best clinical trials provide strong evidence that the
intervention produces, on average, a clinically worthwhile
effect. (Of course such clinical decisions should be informed
by patients’ preferences — for a variety of reasons some
patients will want to continue with an intervention even when
they have very poor outcomes, or discontinue an intervention
even when the outcomes are excellent.)
Clinical outcome measures become more important when
there is little or no evidence from high quality randomised
trials. In that case, the alternatives to relying on clinical
outcome measures are unattractive: we could choose not to
intervene at all, or we could intervene in the absence of high
quality evidence and use potentially misleading low quality
evidence to guide decisions about intervention. In contrast,
when randomised trials provide clear evidence of the effects
of an intervention from high quality clinical trials, clinical
outcome measures become relatively unimportant and
measures of the process of care become more useful. When
evidence of effects of interventions is strong, we should audit
the process of care to see if it is consistent with what the
evidence suggests is good practice. When there is little or no
evidence (i.e. when practice cannot be evidence-based) we
should audit clinical outcomes.
In concluding, we note that there is another role for
measurement of outcomes other than its limited role in telling
us about the effects of intervention. Routine standardised
outcome measurements can be used to generate practice-
specific estimates of prognosis. For example, a
physiotherapist who routinely assesses the presence or
absence of shoulder pain in stroke patients at discharge
following an upper limb rehabilitation program can use those
data to generate practice-specific prognoses about the risk of
developing shoulder pain by the time of discharge. In
addition, as Hahne (2004) and Tuttle (2005) have shown,
simple measures of clinical outcome can provide patient-
specific prognostic information. It is important to recognise
that these data have useful prognostic value, but they do not
provide good evidence of the effectiveness or otherwise of
intervention.
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